Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Another kind of diplomacy

  • Editorial board


Jakarta   /   Fri, October 16 2020   /  01:00 am
A boy looks at Sinovac Biotech LTD's vaccine candidate for COVID-19 coronavirus on display at the China International Fair for Trade in Services (CIFTIS) in Beijing on September 6, 2020. (AFP/Noel Celis)

Beyond the shadow of a doubt, Indonesia’s vaccine diplomacy is reaping rewards. Nearly a year into the COVID-19 outbreak, and despite a very clumsy start to the government’s pandemic response, the country has secured commitments from various foreign partners for the delivery of a future stockpile of more than 300 million doses of vaccine candidates. More deals are likely to be struck, but in theory, Indonesia will have secured vaccine access to a majority of its 274 million population – provided that the resulting medical products are both safe and effective. A great deal of effort has been expended to reach these goals: three Cabinet ministers have been sent abroad to shop around in an effort to save millions of Indonesian lives and an economy on the brink of recession. With 215 or so countries around the world competing for early access to a possible cure ...